Accredited Geriatric Surgery Programs Screen Far More Older Patients for Postoperative Delirium
A new study published in the Journal of the American College of Surgeons found that hospitals with verified geriatric surgery programs screen nearly all older surgical patients for postoperative delirium, while non-accredited programs screen only about half. Postoperative delirium is a serious complication affecting cognitive function in older adults after surgery. The screening gap suggests thousands of cases may go undetected, potentially leaving vulnerable patients without needed intervention.
Research published in the Journal of the American College of Surgeons reveals a significant disparity in delirium screening practices between accredited and non-accredited hospitals. Verified geriatric surgery programs screen nearly every older surgical patient for postoperative delirium, while hospitals without this accreditation screen approximately half of their older patients. Postoperative delirium—acute confusion and cognitive dysfunction following surgery—is a serious complication that can lead to prolonged hospitalization, functional decline, and worse outcomes in elderly patients. The screening gap identified in this study suggests that thousands of cases of postoperative delirium may be going undetected and unaddressed in non-accredited facilities. This finding underscores the importance of standardized protocols and specialized geriatric surgery programs in ensuring comprehensive patient care for older surgical populations.
What's missing
The study's sample size, geographic scope, time period of data collection, and specific screening methods used are not detailed in the provided excerpt. Additionally, the mechanisms explaining why accredited programs achieve higher screening rates and whether improved screening translates to better patient outcomes are not addressed.
What different sources said
- Medical XpressCenter
ACS Geriatric Surgery Verification hospitals screen nearly all older surgical patients for delirium, study finds
Related
Sydney Psychiatrist Retains Medical License After Sexual Assault Conviction
Gopi Ilawala, a Sydney psychiatrist convicted of sexually assaulting an intoxicated colleague in 2022, has been allowed to continue practicing medicine despite the state health regulator seeking to have his registration cancelled. The New South Wales Civil and Administrative Tribunal reprimanded him and imposed conditions rather than striking him off, citing his remorse, lack of prior convictions, and support from two senior psychiatrists. The decision raises questions about professional accountability and public protection in medical regulation.
Australia's TGA to crack down on illegal peptides; government allocates $100m for arthritis research
Australia's Therapeutic Goods Administration has announced a crackdown on illegal peptides due to a surge in imports and online advertising, designating them a priority focus area. The federal government has simultaneously committed $100 million to medical research into arthritis prevention, diagnosis, and treatment. These developments reflect growing regulatory concerns about unregulated drugs and increased investment in chronic disease research.
GLP-1 Drugs Like Ozempic May Help ADHD Symptoms, According to Patient Reports and Clinical Observations
Social media users and some patients are reporting that GLP-1 receptor agonist drugs like Ozempic appear to improve ADHD symptoms, including increased focus, reduced procrastination, and better impulse control. GLP-1s were originally developed to treat Type 2 diabetes but are being studied for various other conditions. While anecdotal reports are growing, no formal clinical trials are currently testing these drugs specifically for ADHD, and the mechanism behind any potential benefit remains unclear.